Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.

JC Gris, C Bourguignon, S Bouvier, É Nouvellon… - Thrombosis …, 2022 - Elsevier
Introduction Limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …

Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes

JC Gris, C Bourguignon, S Bouvier, É Nouvellon… - Thrombosis …, 2022 - hal.science
Introduction: limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …

Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.

JC Gris, C Bourguignon, S Bouvier… - Thrombosis …, 2022 - europepmc.org
Methods We retrospectively analysed thrombotic outcomes after a first COC-associated VTE
and positive aPLAbs, with a low risk HERDOO2 score, on low-dose aspirin (LDA) secondary …

Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes

JC Gris, C Bourguignon, S Bouvier, É Nouvellon… - Thrombosis …, 2022 - elibrary.ru
Introduction. Limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …

Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.

JC Gris, C Bourguignon, S Bouvier… - Thrombosis …, 2022 - thrombosisresearch.com
Introduction Limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …

Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes

JC Gris, C Bourguignon, S Bouvier… - Thrombosis …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …

Combined Oral Contraceptive-Associated Venous Thromboembolism Revealing an Antiphospholipid Syndrome: International Retrospective Study of Outcomes

JCR GRIS, C Bourguignon, S Bouvier… - Eve and Nikolaeva … - papers.ssrn.com
Introduction: Limitations in the data used to define thromboprophylaxis for patients with
antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial …